At AaviGen we are dedicated to advancing heart-specific gene therapies through our unique Adeno-Associated Viral (AAV) vector platform. Our mission is to deliver precise, safe treatments that address the core molecular causes of heart failure, bringing transformative solutions to patients worldwide. With a focus on cardiac innovation, we strive to make a meaningful impact on global heart health by developing therapies tailored to individual patient needs.
Explore more about our work at aavigen.com
#GeneTherapy #HeartHealth #Innovation #Biotech #PrecisionMedicine #HeartFailure #AAV #Technology #Biopharma #Healthcare
Data Privacy: https://aavigen.com/hinweise-zum-datenschutz/
Imprint: https://aavigen.com/imprint-impressum/
Company Details
- Employees
- 11
- Founded
- 2019
- Address
- Im Neuenheimer Feld 440, Heidelberg,baden-Württemberg 69120,germany
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.aavigen.com
- HQ
- Heidelberg, Baden-Württemberg
Aavigen Gmbh Questions
Aavigen Gmbh's website is http://www.aavigen.com
Aavigen Gmbh's LinkedIn profile is https://de.linkedin.com/company/aavigen-gmbh
Aavigen Gmbh has
11 employees.
View email and phone details for 11
employees at Aavigen Gmbh.
Aavigen Gmbh's industry is
Biotechnology Research
Aavigen Gmbh's top competitors are
Protagene,
Bimovis,
Biocontact E.v.,
Excellos,
Snapdragon Chemistry,
Pepperprint Gmbh,
Glas Lerchenmüller Gmbh,
Rheacell Gmbh & Co. Kg,
Sk Pharmteco,
Celonic Group.
Aavigen Gmbh's categories are Biotechnology Research
Aavigen Gmbh's founding year is 2019
